Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis.
about
Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?Accuracy of the Bronchoalveolar Lavage Enzyme-Linked Immunospot Assay for the Diagnosis of Pulmonary Tuberculosis: A Meta-analysisThe specialist physician's approach to rheumatoid arthritis in South AfricaAdvances in the diagnosis and treatment of tuberculosis.Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis.Pilot study of diagnostic potential of the Mycobacterium tuberculosis recombinant HBHA protein in a vaccinated population in Finland.Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic reviewDifferent screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysisThe immunology of tuberculosis: from bench to bedside.Feasibility and diagnostic utility of antigen-specific interferon-gamma responses for rapid immunodiagnosis of tuberculosis using induced sputum.Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatmentNew tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary reportSensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosisIsoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot studyRisks and benefits of biologic therapy for inflammatory bowel diseases.Recent advances in the diagnosis of childhood tuberculosis.QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?Serial testing of health care workers for tuberculosis using interferon-gamma assay.Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma.Diagnosing latent tuberculosis infection in the HIV era.Redefining latent tuberculosis.Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.(®)TB and QFT-GIT).Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays.QuantiFERON-TB Gold Assay on Plasma for Confirmation of Presumed Tuberculosis-Related Uveitis.The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis.Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot.QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia.
P2860
Q22241488-1709073B-9963-4DFD-89D2-3ABEA4410B50Q26750756-EC8ED238-89B9-4E47-B927-F06E08321C0AQ26765122-254E76D9-94C9-4C5D-A314-689B664488F7Q30353049-0E5A2091-2CE2-47C2-9CF0-D71660D5E1D9Q30840526-C98D530F-FA5F-497E-A9C2-072734D3284DQ33294505-E99685B1-CB3D-4206-AA1F-B7CB0175C49AQ33371695-471CAD83-18EF-4F10-A480-B919F86F7D2FQ33521202-313CE3BB-4BFE-421E-996C-D52485E5E38FQ33532816-36836914-9450-4A67-8880-2A7F3E0D8DACQ33777367-ABC9D23D-5429-4B2C-9F9B-6525E58B2B6FQ33815988-6F03E911-E1E3-49DA-88B5-1C6C303DBFBBQ34137874-AC4F70E8-AB84-4837-A266-6129BA8306DAQ34185319-BB391B9C-D27B-46EE-A078-70AAFCBAC6F0Q34527311-5E7BECF1-26A4-46DB-94D7-2AE20FAC5810Q34691242-DAFFAF5C-D42F-4CA4-A6AA-BD4B928C7E8BQ34691255-8A5C3B36-DEC9-4CB0-84F9-7E4EBBD12AA7Q35073163-32262002-E48D-42C4-8651-9FD17A92DA10Q35138740-B4587917-77BE-4421-BFE4-7F69F71FF957Q35629697-2A1CDC9A-9879-4FD4-A91B-8B4CA9413DA1Q35929544-723868CF-4FE2-452E-A0C7-54EA93BCB78EQ36155366-13BB6449-4B5B-42F2-9CB2-310F0C3EEEEBQ36607266-A3A4E195-57B4-46C9-8727-E6E77B5EF9A7Q37110340-D37F5A5A-02E3-483D-8818-C1C22849A064Q37302916-28C5E035-E2DD-44EC-8944-8E0BBBA04390Q37431509-16062D4F-F6A8-4A49-8710-6A3A5B36CAB8Q37940571-908ABF27-34F3-4DCE-A444-3F329334FBF5Q39433439-F85288C2-206A-4CD0-BE9C-B422C88501D7Q40660539-F0DCF639-B87D-47DC-BF4B-D613EE25B1F5Q41960174-24AE03C3-C9D1-48B8-B808-D3A2F8529FD9Q44374379-B79D0EAD-DC66-4D97-A0CC-A283AAD80C69Q45401374-2C13A1E7-B48D-4CC3-A0C4-359BB39ECC94Q46634611-B1293498-D6EB-476E-B076-987837B813EFQ46654948-F720042A-E80A-44F3-8717-9D487E2B3408Q53609951-4D0DBDEF-87F5-41BE-9FE4-0F863E3496F3Q54214232-FBD453C4-A0F0-4A25-B81A-93C820B0BFE0
P2860
Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Utility of the antigen-specifi ...... he management of tuberculosis.
@ast
Utility of the antigen-specifi ...... he management of tuberculosis.
@en
type
label
Utility of the antigen-specifi ...... he management of tuberculosis.
@ast
Utility of the antigen-specifi ...... he management of tuberculosis.
@en
prefLabel
Utility of the antigen-specifi ...... he management of tuberculosis.
@ast
Utility of the antigen-specifi ...... he management of tuberculosis.
@en
P2093
P1476
Utility of the antigen-specifi ...... he management of tuberculosis.
@en
P2093
Graham A W Rook
Margaret A Johnson
Zarir F Udwadia
P304
P356
10.1097/01.MCP.0000158726.13159.5E
P577
2005-05-01T00:00:00Z